Uromems raised €12M in a Series A round in Nov 2016. The company is based in Grenoble, France. Investors in the round: B-to-V Partners, Bpifrance, CEA Investissement and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
